ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
0.00
0.00%
US Tech 100
21,213.60
1.06%
다우존스 지수
44,156.73
0.30%
Bitcoin
102,425.38
-1.17%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. AFC Ajax NV (AJAX) 시세

AFC Ajax NV

AFC Ajax NV (AJAX)

Ajax Resources Plc
9.88
0.04
(0.41%)
마감 23 1월 1:30AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
9.88
매수가
9.88
매도가
9.90
거래량
68
9.86 일간 변동폭 9.90
9.50 52주 범위 10.50
market_cap
181.13M
전일 종가
9.84
개장가
9.90
최근 거래 시간
3
@
9.88
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
1,250
발행 주식
18,333,000
배당수익률
-
주가수익률
-18.57
주당순이익(EPS)
-0.53
매출
233.48M
순이익
-9.75M

AFC Ajax NV 정보

섹터
Sporting & Athletic Gds, Nec
산업
Sporting & Athletic Gds, Nec
웹사이트
www.ajax.nl
본부
Amsterdam, North Holland, Nld
설립됨
-
AFC Ajax NV is listed in the Sporting & Athletic Gds sector of the 유로넥스트 (Euronext) with ticker AJAX. The last closing price for AFC Ajax NV was 9.84 €. Over the last year, AFC Ajax NV shares have traded in a share price range of 9.50 € to 10.50 €.

AFC Ajax NV currently has 18,333,000 shares in issue. The market capitalisation of AFC Ajax NV is 180.40 € million. AFC Ajax NV has a price to earnings ratio (PE ratio) of -18.57.

AJAX 최신 뉴스

추가 뉴스

Ajax I Announces the Separate Trading of its Class A Ordinary Shares and Redeemable Warrants Commencing December 18, 2020

Ajax I (NYSE: AJAX.U) (the “Company”) today announced that, commencing December 18, 2020, holders of the units sold in the Company’s initial public offering of 80,499,090 units completed on...

18 12월 2020
Business Wire
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1009.889.99.767019.85240642DE
40.020.2028397565929.869.989.58789.76650951DE
12009.8810.29.512509.98615275DE
26-0.42-4.0776699029110.310.359.5113910.07411537DE
52-0.62-5.9047619047610.510.59.5139110.22913339DE
156-4.62-31.862068965514.514.69.1189111.29971998DE
260-10.42-51.330049261120.320.99.1249813.58243367DE

AJAX - Frequently Asked Questions (FAQ)

What is the current AFC Ajax NV share price?
The current share price of AFC Ajax NV is 9.88 €
How many AFC Ajax NV shares are in issue?
AFC Ajax NV has 18,333,000 shares in issue
What is the market cap of AFC Ajax NV?
The market capitalisation of AFC Ajax NV is EUR 180.4M
What is the 1 year trading range for AFC Ajax NV share price?
AFC Ajax NV has traded in the range of 9.50 € to 10.50 € during the past year
What is the PE ratio of AFC Ajax NV?
The price to earnings ratio of AFC Ajax NV is -18.57
What is the cash to sales ratio of AFC Ajax NV?
The cash to sales ratio of AFC Ajax NV is 0.78
What is the reporting currency for AFC Ajax NV?
AFC Ajax NV reports financial results in EUR
What is the latest annual turnover for AFC Ajax NV?
The latest annual turnover of AFC Ajax NV is EUR 233.48M
What is the latest annual profit for AFC Ajax NV?
The latest annual profit of AFC Ajax NV is EUR -9.75M
What is the registered address of AFC Ajax NV?
The registered address for AFC Ajax NV is JOHAN CRUIJFF BOULEVARD 29, AMSTERDAM, NORTH HOLLAND, 1101 AX
What is the AFC Ajax NV website address?
The website address for AFC Ajax NV is www.ajax.nl
Which industry sector does AFC Ajax NV operate in?
AFC Ajax NV operates in the SPORTING & ATHLETIC GDS, NEC sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ALMASMastrad
0.0218 €
(122.45%)
24.21M
MLAATAzorean Tech
0.16 €
(60.00%)
1.05k
CDUConduril Engenharia SA
24.60 €
(30.16%)
150
ALNMRNamR SA
0.1745 €
(29.74%)
46.73k
ALSPWSpineway
0.129 €
(28.87%)
960.57k
MLWEYWeya
0.02 €
(-23.08%)
1.5k
ALNEVNeovacs
0.503 €
(-18.87%)
15.62k
ALBIOBiosynex
1.65 €
(-18.32%)
53.17k
POXELPoxel
0.324 €
(-17.03%)
2.44M
ALVETEGEIRO Pharma
0.0912 €
(-16.33%)
4.95k
ATOAtos SE
0.0022 €
(0.00%)
301.81M
BCPBanco Comercial Portugues SA
0.5132 €
(0.16%)
35.61M
ALMASMastrad
0.0218 €
(122.45%)
24.21M
ALVERVergnet
0.0014 €
(0.00%)
17.57M
ALCYBCybergun
0.0001 €
(0.00%)
15.68M

토론

전체 피드 보기
Guido2 Guido2 5 분 전
He wants to hold hands with Ackerman, Carney and Light to see him through the dark hours. Unfortunately, he only has two hands.
FNMA
jour_trader jour_trader 10 분 전
Minutes posted from call, but behind a paywall. 

https://www.pacermonitor.com/public/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al
ELTP
ace65 ace65 16 분 전
When the pigs at the trough get their fill we will have a
HMBL type run.
And the pause of ongoing dilution of course.
HMBL
Dumb&dumber4long Dumb&dumber4long 16 분 전
Let’s focus on TNXP, stick politics somewhere else & other subjects too.
TNXP
22rover 22rover 17 분 전
It's important to remember that legacy holders have invested at or above 0.18 cents. If they are not following sidechannel’s progress, the reality they see is a thinly traded penny stock lingering near its all-time lows.

They phone their broker to sell the stock. Broker says, yeah, i
SDCH
pegs1 pegs1 17 분 전
I think it’s very unprofessional for management to not inform investors of the closing of the lab including departure of scientists! This just continues to be full of surprises ……
CRTG
gp22 gp22 19 분 전
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
gp22 gp22 20 분 전
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
gp22 gp22 20 분 전
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
SkyLimit2022 SkyLimit2022 23 분 전
suit,

Thanks for posting the MHRA link!
https://investorshub.advfn.com/uimage/uploads/2024/10/21/zqal[200.gif
https://investorshub.advfn.com/uimage/uploads/2024/10/24/nqdtigiphy.gif

That’s exactly the kind of regulatory support that Advent has provided wh
NWBO
noradio noradio 23 분 전
Pm'd
DBMM
AlwaysOptimistic AlwaysOptimistic 24 분 전
I agree with you NorCal. Either the current mgt delivers financing this year or just sell the mine as you suggested to a large mining co that can deliver results. Many of us are stuck with shares that have fallen to lows that are not even worth selling. Would like to see a rebound and recoup our or
NB
The GidDy uP Kid The GidDy uP Kid 28 분 전
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
The GidDy uP Kid The GidDy uP Kid 28 분 전
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
The GidDy uP Kid The GidDy uP Kid 28 분 전
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
harry crumb harry crumb 30 분 전
Lets see 1.50 tomorrow or lower boys! Jam it at open! Lets roll $$$$$$
ILLR
XMaster2023 XMaster2023 30 분 전
Theory, Approval of DCVax is near!
NWBO
Plato_ Plato_ 31 분 전
Yup, that's the way I understand it. Whether the contract is paid up front or on performance, the revenue is recognized when earned and deferred revenue is reduced to match. Good example with the labor-based contract. Same principle. You make a good point about the intellectual property. If this is
GDVM
boi568 boi568 31 분 전
Statutes and regulations will always trump guidances, assuming the statutes or regulations address the issue the guidance is addressing. The reason agencies issue guidance is because the statutes and regulations haven't addressed the issue.

So, if you can find an FDA statute or regula
AVXL
boi568 boi568 31 분 전
Statutes and regulations will always trump guidances, assuming the statutes or regulations address the issue the guidance is addressing. The reason agencies issue guidance is because the statutes and regulations haven't addressed the issue.

So, if you can find an FDA statute or regula
AVXL
3331 3331 32 분 전
3331 has been restricted to one post per day:

BIEL HITS COPPER "IN THE BLINK OF AN EYE" WHEN THE FOLLOWING OCCURS!

pps > .001 after management drops some positive hints. The Golden Cross (already achieved) and Blue Sky Breakout will get the technicians/chartists attenti
QUBT SERV
theorysuit theorysuit 34 분 전
https://cms.mhra.gov.uk/mhra/mia/uk-miaimp-54923

Oh you are talking about this MIA. Unfortunately, i only see ADVENT on this MIA. No sight of NWBO at all. Like i said congrats to LP not NWBO.


https://find-and-update.company-information.service.gov.uk/company
NWBO
HomerRomer HomerRomer 35 분 전
This is a response to Missling’s LinkedIn post by a VERY educated and qualified senior vice president of Red Nucleus who manages and provides strategic oversight and tactical back up for clinical teams.  He seems to think Blarcamesine  could likely work better than the study results show. 
AVXL

최근 히스토리

EU
AJAX
AFC Ajax NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유